For many seniors, the morning routine involves a complex choreography of pill organizers and prescription bottles. While these medications are often life-saving, the accumulation of prescriptions—known as polypharmacy—can eventually create a new set of health risks that outweigh the benefits of the drugs themselves.
The stakes are significant. According to the Canadian Association for the Protection of Medical Rights (ACPM), an individual taking 10 or more medications faces a risk of drug-drug interactions eight times higher than someone taking only two prescriptions. This precarious balance is driving a critical but difficult conversation in geriatric medicine: deprescribing in seniors.
Deprescribing is not simply about stopping medication. it is the planned and supervised process of reducing or stopping drugs that may no longer be beneficial or may be causing harm. As the population ages and medical science allows people to live longer with multiple chronic conditions, the necessitate for a strategic “exit plan” for certain medications has become a public health priority.
Dr. Armand Aalamian, administrative director of Safe Medical Care and Equity, Diversity and Inclusion at the ACPM, suggests that the root of the problem is a global “culture of medication.” He notes that when patients visit a doctor with a concern, there is often a reflex—from both the provider and the patient—to leave the office with a tangible treatment in hand.
This reflex creates a psychological barrier to reduction. Dr. Aalamian observes that it can feel counterintuitive to stop a treatment, often leading patients to request, “Why are you stopping this?” when a physician suggests a reduction.
The Medico-Legal Risks of Stopping Treatment
While the clinical goal of deprescribing is to improve quality of life, the process is fraught with professional risk for physicians. A study analyzing 31 medico-legal files involving seniors aged 65 and older highlighted the tension between medical necessity and legal liability. Of those cases, 27 involved complaints to medical regulatory authorities and four involved civil litigation.
In 15 of these instances, expert critics raised concerns regarding how the deprescribing was handled. This suggests that even when a doctor is acting in the patient’s best interest, the act of removing a drug can be perceived as a failure of care or a catalyst for a health decline.
The medications most frequently involved in these disputes are those used to treat pain, mood disorders, and anxiety. Specifically, analgesics, benzodiazepines, and opioids are the most common targets for deprescribing.
These drugs present a double challenge: they are often used for conditions that are difficult to manage, and they carry a high risk of physical and psychological dependence. Dr. Aalamian notes that it is not uncomplicated for patients to let proceed of dependencies, which can lead to friction between the patient and the provider if the transition is not handled with extreme care.
A Roadmap for Safe Medication Reduction
To mitigate risks, the ACPM has developed tools and guidelines to help physicians navigate the process of deprescribing in seniors. The goal is to shift the focus from “what can we add” to “what can we safely remove.”
A safe deprescribing protocol typically follows a structured sequence:
- Comprehensive Review: The physician analyzes the patient’s entire medical history and the specific relationship between their current diseases and medications.
- Benefit-Risk Analysis: The provider determines if a drug is still indicated or if the side effects have begun to outweigh the clinical benefits.
- Gradual Tapering: Rather than abrupt cessation, the dose is decreased slowly to avoid withdrawal symptoms or a rebound of the condition.
- Continuous Monitoring: Strict medical follow-up is established to ensure the patient remains stable.
- Rigorous Documentation: The physician’s reasoning for the reduction must be clearly documented in the medical record so that other healthcare providers are aware of the strategy.
Communication remains the most critical variable. Dr. Aalamian emphasizes that a “well-informed reasoning” must be discussed thoroughly with the patient. Success depends on a shared agreement and a clear action plan, ensuring the patient feels supported rather than abandoned by their treatment.
The Challenge of Fragmented Care
One of the primary obstacles to successful deprescribing is the lack of integrated health information. Many seniors are treated by a variety of specialists—cardiologists, endocrinologists, and general practitioners—whose medical records may not be synchronized.
When records are scattered, the risk of conflicting prescriptions increases, and the effort required to safely deprescribe grows. Without a single, shared view of the patient’s medication list, physicians may be hesitant to stop a drug prescribed by another provider for fear of disrupting a necessary treatment.
| Medication Class | Primary Use | Common Deprescribing Challenge |
|---|---|---|
| Benzodiazepines | Anxiety/Insomnia | High risk of psychological dependence |
| Opioids | Severe Pain | Physical withdrawal and addiction |
| Analgesics | Chronic Pain | Patient fear of returning pain |
| Psychotropics | Mood Disorders | Complexity of mental health stability |
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before making any changes to your medication regimen.
As healthcare systems move toward more integrated digital records, the ability to conduct comprehensive medication reviews is expected to improve. The next phase for many medical associations involves refining these clinical guidelines to ensure that the goal of “less is more” is achieved without compromising patient safety.
Do you or a loved one manage multiple prescriptions? Share your experiences with medication reviews in the comments below.
Related reading
